The Healthcare Providers’ Association of Nigeria (HCPAN) has formally requested the National Assembly to withdraw the proposed National Health Facility Regulatory Agency of Nigeria (NHFRA) Bill, citing significant risks of administrative duplication and an escalation in healthcare delivery costs. The association, which serves as the primary representative body for private healthcare providers across the federation, articulated its opposition during a high-profile press briefing in Lagos. This public stance follows the submission of a comprehensive memorandum by HCPAN to the Senate Committee on Health during a recent public hearing on the proposed legislation.
The crux of HCPAN’s argument rests on the assertion that the establishment of a new regulatory agency would not only replicate the functions of existing statutory bodies but would also introduce an unnecessary layer of bureaucracy into a sector already struggling with inflationary pressures and infrastructural deficits. Dr. Austine Aipoh, the President of HCPAN, emphasized that while the association remains a staunch advocate for high clinical standards and patient safety, the NHFRA Bill represents a fragmented approach to regulation rather than a cohesive improvement of the current system.
A Landscape of Regulatory Redundancy
The proposed NHFRA Bill seeks to create an agency tasked with the inspection, accreditation, certification, and monitoring of healthcare facilities nationwide. However, HCPAN points out that these responsibilities are already enshrined in the mandates of several established institutions. At the federal level, the Federal Ministry of Health and Social Welfare maintains oversight of national health policies and tertiary institutions. Simultaneously, State Ministries of Health, through their respective private health facility monitoring and accreditation agencies, manage the licensing and operation of hospitals and clinics within their jurisdictions.
Furthermore, professional regulatory councils—such as the Medical and Dental Council of Nigeria (MDCN), the Pharmacy Council of Nigeria (PCN), the Nursing and Midwifery Council of Nigeria (NMCN), and the Medical Laboratory Science Council of Nigeria (MLSCN)—already possess the statutory power to regulate the premises where their members practice. For instance, the PCN is legally empowered to inspect and register all premises where pharmaceutical services are provided, while the MDCN oversees the clinical standards of medical practices.
HCPAN argues that adding the NHFRA to this mix would subject healthcare providers to a "multiplicity of regulators," leading to a scenario where a single facility could face five or six different inspection teams in a single calendar year, each demanding separate compliance fees and administrative documentation.
Economic Implications for Providers and Patients
One of the most pressing concerns raised by the association is the financial burden that the new agency would impose on the private health sector. In Nigeria, the private sector accounts for a significant portion of healthcare delivery, often filling the gaps left by overstretched public institutions. The introduction of new regulatory fees, accreditation costs, and the administrative overhead required to manage multiple regulatory relationships would inevitably lead to an increase in the cost of medical services.
"Rather than simplifying healthcare regulation, the Bill risks creating an additional layer of bureaucracy that will increase compliance costs without necessarily improving patient outcomes," Dr. Aipoh stated during the Lagos briefing. He warned that in an economy where out-of-pocket expenditure remains the primary means of healthcare financing for over 70% of the population, any increase in provider costs would be directly passed on to patients, further limiting access to essential services.
The association also highlighted the potential for conflict between federal and state jurisdictions. Under the Nigerian Constitution, health is a concurrent matter, meaning both federal and state governments have the authority to legislate on it. HCPAN contends that the NHFRA Bill could lead to legal disputes over which tier of government has the ultimate authority to license and shut down facilities, creating a chaotic environment for investors and practitioners alike.
Chronology of the Legislative Challenge
The opposition to the NHFRA Bill has been building over several months as the legislation progressed through the National Assembly. The timeline of events highlights a growing consensus among healthcare stakeholders regarding the Bill’s flaws:
- Introduction of the Bill: The National Health Facility Regulatory Agency Bill was introduced to the Senate with the stated aim of harmonizing healthcare standards across Nigeria and ensuring that all facilities meet a minimum threshold of quality.
- Stakeholder Review: Upon the Bill’s publication, various professional bodies began reviewing its provisions, noting immediate overlaps with the National Health Act of 2014 and the statutes governing professional councils.
- Senate Public Hearing: The Senate Committee on Health convened a public hearing to gather input from stakeholders. It was during this session that HCPAN, alongside other groups, submitted formal memoranda outlining their objections.
- HCPAN Press Briefing: Following the public hearing, HCPAN organized a media session in Lagos to sensitize the public and the executive arm of the government about the long-term implications of the Bill, seeking to move the conversation from legislative halls to the national stage.
Supporting Data and Sectoral Context
The Nigerian healthcare sector is currently operating under extreme duress. According to data from the World Health Organization (WHO) and the Nigerian Bureau of Statistics (NBS), the country’s health infrastructure requires massive investment to meet the Sustainable Development Goals (SDGs). Currently, Nigeria’s healthcare spending as a percentage of GDP remains below the recommended levels, and the "brain drain" phenomenon—commonly referred to as the ‘Japa’ syndrome—has seen thousands of doctors and nurses leave the country for better opportunities abroad.
In this context, HCPAN argues that the government’s focus should be on the "Ease of Doing Business" within the health sector. Excessive regulation is often cited as a deterrent to private sector investment. By creating more hurdles for clinic owners and diagnostic center operators, the NHFRA Bill could inadvertently stifle the growth of the very facilities needed to reduce the patient-to-doctor ratio.
Supporting this view, the Association of Community Pharmacists of Nigeria (ACPN) joined HCPAN in its protest. The ACPN noted that the pharmaceutical sub-sector is already one of the most heavily regulated in the country. They argued that the resources required to fund a new federal agency could be better spent on upgrading the equipment and training of existing regulatory staff at the state level.
Analysis of Proposed Alternatives
HCPAN has not merely called for the rejection of the Bill but has proposed a constructive alternative: the development of a National Healthcare Regulatory Coordination Framework. This framework would focus on:
- Harmonization: Creating a unified protocol where existing regulators (MDCN, PCN, etc.) share data and coordinate inspection schedules to avoid redundancy.
- Digitization: Moving the accreditation and licensing processes online to reduce human interface, minimize corruption, and speed up compliance.
- Strengthening Existing Bodies: Allocating the proposed budget for the NHFRA to the Federal Ministry of Health and professional councils to enhance their current monitoring and enforcement capabilities.
- Joint Inspections: Implementing a system where a single multi-disciplinary team carries out an all-encompassing inspection of a facility, representing all relevant regulatory interests at once.
This approach aligns with the federal government’s broader policy of reducing the cost of governance, as seen in the discussions surrounding the Oronsaye Report, which recommends the merging of agencies with overlapping functions to save costs and improve efficiency.
Broader Implications and the Path Forward
The outcome of this legislative battle will have far-reaching consequences for the Nigerian healthcare system. If the Bill is passed in its current form, the immediate impact will likely be a surge in litigation as professional councils and state governments challenge the federal agency’s encroachment on their traditional roles. Furthermore, the private health sector may see a slowdown in expansion at a time when the government is actively seeking private-public partnerships to bridge the healthcare gap.
Conversely, if the National Assembly heeds the advice of HCPAN and other stakeholders, it could mark a turning point toward a more collaborative and efficient regulatory environment. Such a move would signal to the international community and local investors that Nigeria is committed to evidence-based policy-making and the reduction of administrative bottlenecks.
As the Senate Committee on Health reviews the submissions from the public hearing, the healthcare community remains on high alert. HCPAN has reaffirmed its commitment to working with the Federal Ministry of Health and Social Welfare and the National Assembly to ensure that any new regulations are practical, sustainable, and, above all, beneficial to the Nigerian patient. The association maintains that the goal of regulation should be to facilitate quality care, not to create a complex web of oversight that hampers the delivery of life-saving services.
